Batavia Biosciences - PATH collaboration polio vaccines
Batavia Biosciences receives $2.2 million follow-up grant from PATH to support new tools for polio eradication era
08. Juli 2019 07:00 ET | Batavia Biosciences B.V.
Leiden, 4 Jul 2019 – Today, Batavia Biosciences announces it received a follow-up grant of $2.2 million from PATH – a global organization dedicated to health equity – to develop and manufacture novel...